Surrozen (SRZN)

• Market cap: $324M
• 1 day: 6.66%
• 5 days: 20.1%
• 1 month: 24.9%
• 3 months: 59.25%
• 6 months: 133.5%
• Year to date: 47.8%
• 1 year: 235.62%
• 5 years: -78.51%
• 10 years: -79%
• Sector: Healthcare
• Industry: Biotechnology

About: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Employees: 44